We assign a narrow moat rating for Alibaba Health due to its network effect from the number of healthcare merchants, pharmacies, and online doctors on its platform, and intangible assets that come ...

Alibaba’s CMR and Cloud growth rebound, AI tailwinds, and easing U.S.-China tensions signal upside. Read why BABA stock is a ...

Alibaba (BABA -0.43%) stock has had a good start to 2025, but it was giving back some of its gains after its fiscal ...

Analyst maintained Buy rating, lowered price target for Alibaba. Q4 revenue missed estimates due to divestitures, but strong ...

BABA has an average analyst rating of buy and is -23.35% away from its mean target price of $163.2 per share Its trailing earnings per share (EPS) is $6.91 Alibaba has a trailing 12 month Price to ...

We estimate that the rising adoption of Quanzhantui should help Alibaba enhance monetization until fiscal 2026.

Good day, ladies and gentlemen. Thank you for standing by. Welcome to Alibaba Group’s March Quarter 2025 and Full Fiscal Year ...

FY2025 estimates, sparking a BABA stock sell-off despite strong long-term prospects. Read why BABA stock is a strong buy.

Chinese tech heavyweight Alibaba Group Holding Ltd reported on Thursday night that its revenue stood at 236.45 billion yuan ...

Major Chinese e-commerce platforms have ramped up efforts to offer steep discounts and consumption coupons as well as to ...

Alibaba posted quarterly revenue that missed analysts' estimates on Thursday, as the e-commerce group works on new strategies ...

Alibaba shares fell on Thursday after the Chinese e-commerce giant missed earnings expectations for its fiscal fourth quarter ...